Company intelligence / Profile preview

NOxBOX

United Kingdom

Ownership: Private
Development stage: Other

Overview

NOxBOX manufactures the NOxBOXi delivery system, which has been in commercial use in 40+ countries since 2013 and in the US since October 2018. The company submitted the NOxBox I Plus for FDA 510(k) clearance with enhancements including streamlined setup and improved ventilator compatibility. A Class I recall affecting 750+ devices was issued in July 2023 due to a misaligned check valve in the internal manifold.

Therapeutic areas: Pulmonology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Authorized distributor network globally

Beyond the preview

Go deeper on NOxBOX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NOxBOX.

Explore the full profile